Modulation of SOX2 expression delineates an end-point for paclitaxel-effectiveness in breast cancer stem cells
Crossref DOI link: https://doi.org/10.1038/s41598-017-08971-2
Published Online: 2017-08-23
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mukherjee, Pritha
Gupta, Arnab
Chattopadhyay, Dhrubajyoti
Chatterji, Urmi
Text and Data Mining valid from 2017-08-23
Version of Record valid from 2017-08-23
Article History
Received: 8 February 2017
Accepted: 20 July 2017
First Online: 23 August 2017
Competing Interests
: The authors declare that they have no competing interests.